Patent · US Active

Compounds

US10836791B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

DSM IP ASSETS B.V. · NL

Inventors

Marc Heidl · Weil am Rhein, DE
Eileen Jackson · Kaiseraugst, CH

Key dates

Filing date	Sep 13, 2017
Grant date	Nov 17, 2020
Priority date	—
Expiry date	Sep 29, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61Q19/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel compounds which effectively inhibit the melanin synthesis in human melanocytes and are thus suitable for the treatment of senile lentigines, for smoothening skin color irregularities and/or for lightening natural skin color.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.